In a separate ovarian cancer study anti-ICAM-1 blocking antibodies only partly blocked CD8+ T cell infiltration, suggesting that additional molecules like VCAM-1 may mediate CD8+ T cell extravasation as well (10). This evidence concerns the gene ICAM1 and ovarian carcinoma.